Sobi
A Senior Market Access Specialist at Sobi in Italy, responsible for defining and implementing strategies to ensure access to therapies for rare diseases, aligning with Sobi's values of Care, Ambition, Partnership, and Ownership.
Headquarters
Stockholm, Stockholm, Sweden
Company Size
1001-5000 employees
Founded
2009
Sobi is a specialised international biopharmaceutical company focused on transforming the lives of people with rare diseases by developing and delivering innovative medicines. The company invests heavily in R&D and maintains a strong pipeline, with expanded patient access and commercialization as core priorities. Headquartered in Stockholm, Sobi operates globally and partners with healthcare providers, patient communities and other stakeholders to bring novel therapies to market. It also emphasizes sustainability, transparency and investor engagement as part of its long‑term strategy.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sobi.
Sobi didn’t post a salary, so this is our estimate from similar listings.
Market Access Lead
Novo Nordisk A/S
Executive Director, Respiratory Value & Access Lead
Insmed Incorporated
Director Market Access - Rare Diseases (EU4 + UK)
Regeneron Pharmaceuticals
Director, Market Access (Rare Diseases)
Regeneron Pharmaceuticals
Director of Market Access
WEP Clinical
Director, Market Access Pipeline
Regeneron Pharmaceuticals